Kidney Res Clin Pract.  2022 Jul;41(4):508-520. 10.23876/j.krcp.21.193.

Efficacy and safety of rapid intermittent bolus compared with slow continuous infusion in patients with severe hypernatremia (SALSA II trial): a study protocol for a randomized controlled trial

Affiliations
  • 1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
  • 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
  • 3Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea
  • 4Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea
  • 5Department of Emergency Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
  • 6Clinical Preventive Medicine Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
  • 7School of AI Convergence, Hallym University, Chuncheon, Republic of Korea
  • 8Department of Statistics and Institute of Statistics, Hallym University, Chuncheon, Republic of Korea
  • 9Center for Artificial Intelligence in Healthcare, Seoul National University Bundang Hospital, Seongnam, Republic of Korea

Abstract

Background
Hypernatremia is a common electrolyte disorder in children and elderly people and has high short-term mortality. However, no high-quality studies have examined the correction rate of hypernatremia and the amount of fluid required for correction. Therefore, in this study, we will compare the efficacy and safety of rapid intermittent bolus (RIB) and slow continuous infusion (SCI) of electrolyte-free solution in hypernatremia treatment. Methods: This is a prospective, investigator-initiated, multicenter, open-label, randomized controlled study with two experimental groups. A total of 166 participants with severe hypernatremia will be enrolled and divided into two randomized groups; both the RIB and SCI groups will be managed with electrolyte-free water. We plan to infuse the same amount of fluid to both groups, for 1 hour in the RIB group and continuously in the SCI group. The primary outcome is a rapid decrease in serum sodium levels within 24 hours. The secondary outcomes will further compare the efficacy and safety of the two treatment protocols. Conclusion: This is the first randomized controlled trial to evaluate the efficacy and safety of RIB correction compared with SCI in adult patients with severe hypernatremia.

Keyword

Cerebral edema; Electrolyte-free water; Hypernatremia; Hypotonic solution; Treatment
Full Text Links
  • KRCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr